Biotechnology Group Leader:

Drew Lowery, Ph.D.
Dr. Lowery has led and worked on projects representing a wide array of technologies, such as single molecule nucleic acid amplification and sequencing, pharmaceutical formulation and dosing, satiety hormones, microfludics integrated systems, and biofuel production, among others. He directs all biological sequence searching efforts and specializes in cost efficient strategies for complicated cases. Dr. Lowery launched the Accelerated Examination Support practice, where his searches have been favorable reviewed by the USPTO, leading to patent granting for his clients. Dr. Lowery holds a Ph.D. in Biochemistry from the Massachusetts Institute of Technology where he studied cancer signaling networks.

Project Managers:

David Adamovich, Ph.D.
Ph.D. in Biological and Biomedical Sciences, Harvard University
Expertise in microbiology, genomics, therapeutic formulations

Ben Leung, Ph.D.
Ph.D. in Molecular and Cellular Biology, University of Washington
Expertise in neuroscience, food formulation, genetics

Additional Expertise:

Vadim Demidov, Ph.D.
Ph.D. in Biophysics, Institute of Molecular Genetics of USSR Academy of Sciences
Expertise in PCR & sequencing methodologies, microfluidics

Ypsita Demunshi, L.L.M., B.Tech.
L.L.M. in IP Law, George Washington University
Expertise in molecular biology, pharmaceutical delivery

Cecilia Martin, Ph.D.
Ph.D. in Neurobiology and Biomedical Sciences, Universidad Nacional Autonoma de Mexico (UNAM)
Expertise in neuroscience, endocrinology, molecular biology

Sivanne Pearl-Waserman, Ph.D.
Ph.D. in Molecular and Cell Biology, Brandeis University
Expertise in molecular biology, bacterial genetics, cell biology and biochemistry


For inquires contact:

Drew Lowery, Ph.D.
Group Leader - Biotechnology & Pharmaceuticals
Phone: US (1) 617.574.9574